Does nose picking lead to dementia? Researchers Dr Joyce Siette and Professor Mark Patrick Taylor analyse a recent study that has generated a lot of media interest.
Study identifies link between COVID-19 and Parkinson’s Researchers say the virus aggravates brain cells similar to neurodegenerative conditions, flagging potential future risk, but also treatments.
CT Coronary Calcium Scores In Cardiovascular Risk Assessment Dr Vance Manins, a cardiologist with a special interest in advanced cardiac failure and cardiac imaging, explains the difference between CT coronary calcium scores and CT coronary angiography.
Polycystic kidney disease Dhineli Perera chats to nephrologist Gopi Rangan about autosomal dominant polycystic kidney disease – simple interventions, drug treatment and pain management.
Upcoming MBS changes GPs need to know From 1 November, a number of MBS changes will be instituted that are likely to have some impact on general practice.
New clinical support for ‘silent but deadly’ disease Chronic kidney disease detection and management resources have been released, days after it was labelled a ‘national emergency’.
SGLT2 inhibitors for kidney and heart disease Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease.
New Alzheimer’s medication found to slow cognitive decline The drug may be available as early as 2023, but there are still hurdles to cross, write Bernadette McGuinness and Elizabeth Coulthard.
Could ‘nurse navigators’ help the severely mentally ill? People with serious mental illness are dying much earlier than average from entirely preventable diseases, a situation a new policy aims to improve.
New PIP QI dataset provides ‘snapshot’ of general practice More than 5600 general practices took part in the program – but given the current pandemic environment, how much insight is it providing?